Published: 7 June 2019
Publications
Recent approvals of medicines containing a new active ingredient
Prescriber Update 40(2): 37
June 2019
For the period 16 January 2019 to 15 April 2019.
| Trade name (Active ingredient) |
Dose form and strength(s) | herapeutic area |
|---|---|---|
| Agrylin (anagrelide) | Capsule 0.5 mg |
Essential thrombocythaemia |
| Phenasen (arsenic trioxide) | Concentration for injection 10 mg/10 mL |
Acute promyelocytic leukaemia (APL) |
See the Medsafe Product/Application
search for more information about these medicines.
Data sheets of currently
marketed medicines are also available.
